Publication | Open Access
Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer
11
Citations
33
References
2019
Year
Ganetespib might be a promising therapeutic option for the treatment of patients with EGFR-TKI-resistant NSCLC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1